Revolo Biotherapeutics Awarded Innovation Passport for '1805 in the United Kingdom for the Treatment of Moderate to Severe Rheumatoid Arthritis
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com